Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Synthesis of New 3-Arylcoumarins Bearing N-Benzyl Triazole Moiety: Dual Lipoxygenase and Butyrylcholinesterase Inhibitors With Anti-Amyloid Aggregation and Neuroprotective Properties Against Alzheimer’S Disease Publisher



Pourabdi L1 ; Kucukkilinc TT2 ; Khoshtale F1 ; Ayazgok B2 ; Nadri H3 ; Farokhi Alashti F1 ; Forootanfar H4 ; Akbari T5 ; Shafiei M6 ; Foroumadi A6, 7 ; Sharifzadeh M8 ; Shafiee Ardestani M9 ; Abaee MS1 ; Firoozpour L6 Show All Authors
Authors
  1. Pourabdi L1
  2. Kucukkilinc TT2
  3. Khoshtale F1
  4. Ayazgok B2
  5. Nadri H3
  6. Farokhi Alashti F1
  7. Forootanfar H4
  8. Akbari T5
  9. Shafiei M6
  10. Foroumadi A6, 7
  11. Sharifzadeh M8
  12. Shafiee Ardestani M9
  13. Abaee MS1
  14. Firoozpour L6
  15. Khoobi M7, 9
  16. Mojtahedi MM1
Show Affiliations
Authors Affiliations
  1. 1. Department of Organic Chemistry and Natural Products, Chemistry and Chemical Engineering Research Center of Iran, Tehran, Iran
  2. 2. Faculty of Pharmacy, Department of Biochemistry, Hacettepe University, Ankara, Turkey
  3. 3. Department of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
  4. 4. Pharmaceutical Sciences and Cosmetic Products Research Center, Kerman University of Medical Sciences, Kerman, Iran
  5. 5. Department of Microbiology, Islamic Azad University, North Tehran Branch, Tehran, Iran
  6. 6. Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
  7. 7. Pharmaceutical Sciences Research Center, The institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran
  8. 8. Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
  9. 9. Department of Radiopharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran

Source: Frontiers in Chemistry Published:2022


Abstract

A novel series of coumarin derivatives linked to the N-benzyl triazole group were synthesized and evaluated against 15-lipoxygenase (15-LOX), and acetyl- and butyrylcholinesterase (AChE and BuChE) to find the most potent derivative against Alzheimer’s disease (AD). Most of the compounds showed weak to moderate activity against ChEs. Among the most active BuChE and 15-LOX inhibitors, 8l and 8n exhibited an excellent neuroprotective effect, higher than the standard drug (quercetin) on the PC12 cell model injured by H2O2 and significantly reduced aggregation of amyloid Aβ1-42, with potencies of 1.44 and 1.79 times higher than donepezil, respectively. Compound 8l also showed more activity than butylated hydroxytoluene (BHT) as the reference antioxidant agent in reducing the levels of H2O2 activated by amyloid β in BV2 microglial cells. Kinetic and ligand–enzyme docking studies were also performed for better understanding of the mode of interaction between the best BuChE inhibitor and the enzyme. Considering the acceptable BuChE and 15-LOX inhibition activities as well as significant neuroprotection, and anti-amyloid aggregation activities, 8l and 8n could be considered as potential MTDLs for further modification and studies against AD. Copyright © 2022 Pourabdi, Kucukkilinc, Khoshtale, Ayazgok, Nadri, Farokhi Alashti, Forootanfar, Akbari, Shafiei, Foroumadi, Sharifzadeh, Shafiee Ardestani, Abaee, Firoozpour, Khoobi and Mojtahedi.
Other Related Docs